Tango Therapeutics, Inc. Public Market Comparables
Find the most relevant public market comparables for Tango Therapeutics, Inc., including EV/Revenue and EV/EBITDA multiples to help you make informed investment decisions.
Company Overview
Tango Therapeutics is a clinical-stage biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. They leverage the genetic principle of synthetic lethality to discover and develop therapies targeting critical cancer targets.
Business Model
Discovery and development of precision oncology therapies, specifically novel small molecules targeting cancer drivers not addressed by current drugs.
Target Customers
Cancer patients.
Specific Focus
Developing therapies based on the genetic principle of synthetic lethality, focusing on targets such as PRMT5 and CoREST.
Location
Boston, Massachusetts
CEO
Barbara Weber
Industry
Life sciences
Sub Sector
Precision Oncology
3yr Revenue Growth
377%
Website
Public Market Comparables
Below are the key valuation metrics for companies similar to Tango Therapeutics, Inc. in the Biotechnology sector. These metrics can help you understand how the market values companies with similar business models and growth profiles.
Looking for a comprehensive compset for Tango Therapeutics, Inc.? Our platform provides detailed analysis of Tango Therapeutics, Inc.'s competitive landscape, including financial metrics, growth trends, and market positioning. Get access to the full Tango Therapeutics, Inc. compset by trying our platform today.
EV/Revenue Multiple
Min
0.0x
Median
0.0x
Max
00.0x
Unlock actual values by trying our platform
View Full DetailsEV/EBITDA Multiple
Min
00.0x
Median
00.0x
Max
00.0x
Unlock actual values by trying our platform
View Full Details
Unlock the Full Tango Therapeutics, Inc. Compset
As a leading player in the Life sciences industry within the Biotechnology sector, Tango Therapeutics, Inc. operates in the specialized Precision Oncology sub-sector. Understanding how Tango Therapeutics, Inc. compares to its public market comps is essential for accurate valuation and strategic decision-making.
Our comprehensive analysis includes detailed comparables (compsets) featuring similar companies in the Precision Oncology space, with complete financial metrics, growth trajectories, and competitive positioning insights that go beyond the surface-level data shown above.
Other Interesting Companies
Sutro Biopharma Inc.
Biotechnology • Life sciences
Sutro Biopharma, Inc. is a clinical-stage oncology company focused on discovering and developing precisely designed cancer therapeutics using its proprietary cell-free protein synthesis platform, XpressCF+. The company develops next-generation protein therapeutics for cancer and autoimmune disorders, focusing on antibody-drug conjugates (ADCs), cytokine-based immuno-oncology therapies, and bispecific antibodies.
Foghorn Therapeutics Inc.
Biotechnology • Life sciences
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company focused on discovering and developing a new class of medicines that target genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform provides a mechanistic understanding of how components of this system interact, enabling the identification and validation of potential drug targets. The company is developing therapies for various cancers, including hematologic cancers and solid tumors.
Molecular Templates, Inc.
Biotechnology • Life sciences
A clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells using a proprietary drug platform technology, Engineered Toxin Bodies (ETBs), to create novel therapies with potent and differentiated mechanisms of action for cancer and various disease indications. The company is no longer operating.
Get Your Custom Comparable Analysis
Need a more detailed analysis of Tango Therapeutics, Inc. and its public market comparables? Our platform provides comprehensive valuation metrics, growth analysis, and more.
Try CompsetFinder Free